Session Datesort descending
Nephrology and Hypertension M and M Conference January 16 2026 01/16/2026 - 7:30am to 8:30am
Nephrology and Hypertension Final Results of the ILLUMINATE A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1 January 23 2026 01/23/2026 - 7:30am to 8:30am
Nephrology and Hypertension A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody mediated rejection in kidney transplant recipients January 30 2026 01/30/2026 - 7:30am to 8:30am
Nephrology and Hypertension Performance of Large Language Models in Analyzing Common Hypertension Scenarios February 6 2026 02/06/2026 - 7:30am to 8:30am
Nephrology and Hypertension Outcomes of Solid Organ Transplant Recipients with Advanced Cancers Receiving Immune Checkpoint Inhibitors February 20 2026 02/20/2026 - 7:30am to 8:30am
Nephrology and Hypertension M and M Conference February 27 2026 02/27/2026 - 7:30am to 8:30am
Nephrology and Hypertension Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence April 3 2026 04/03/2026 - 7:30am to 8:30am
Nephrology and Hypertension Deep biochemical phenotyping reveals prognostic value of rare genetic variants in adult kidney stone disease April 10 2026 04/10/2026 - 7:30am to 8:30am
Nephrology and Hypertension Trial of Pegcetacoplan in C3 Glomerulopathy and Immune Complex MPGN April 24 2026 04/24/2026 - 7:30am to 8:30am